In 2008, Sledziewski and coworkers94 measured levels of DNA methylation in three marker genes (SEPT9, NGFR, TMEFF2) in human plasma samples from CRC patients or healthy controls, of which SEPT9 was proved to be the most specific one. The gene discussed is SEPTIN9; the disease is colorectal carcinoma.